Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Aarti Drugs has informed that the meeting of Board of Directors is scheduled to be held on Tuesday, 13th February, 2018, to consider, approve and take on record Audited Financial Results and Accounts for the quarter and nine months ended 31st December, 2017.
The above information is a part of company’s filings submitted to BSE.